Renal papillary necrosis due to naproxen.
A 31-year-old man with rheumatoid arthritis, who had previously been treated with sulindac, fenoprofen calcium, high dose salicylates and gold salts, developed renal papillary necrosis (RPN) 4 months after institution of naproxen therapy. No other factor predisposing to RPN could be discovered. Sulindac was substituted for naproxen and no further adverse renal effects occurred over the next 12 months. We review previous reports linking RPN to antiinflammatory drug use and discuss possible advantages of sulindac in patients who have experienced renal toxicity from other antiinflammatory agents.
D000328:Adult; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D006801:Humans; D007681:Kidney Papillary Necrosis / Q000139:chemically induced*; D008297:Male; D009288:Naproxen / Q000009:adverse effects*; D013467:Sulindac / Q000627:therapeutic use
D013467:Sulindac; D009288:Naproxen